Correction: Mu heavy chain disease with MYD88 L265P mutation: An unusual manifestation of lymphoplasmacytic lymphoma
Saved in:
Main Authors: | Vandana Baloda (Author), Sarah E. Wheeler (Author), David L. Murray (Author), Mindy C. Kohlhagen (Author), Jeffrey A. Vos (Author), Svetlana A. Yatsenko (Author), Mounzer E. Agha (Author), Miroslav Djokic (Author), Steven H. Swerdlow (Author), Nathanael G. Bailey (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma
by: Vandana Baloda, et al.
Published: (2022) -
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
by: Junbin Chen, et al.
Published: (2020) -
MyD88 signalling is critical in the development of pancreatic cancer cachexia
by: Xinxia Zhu, et al.
Published: (2019) -
IJCM_265A: Cellular Consequences of Fruit Juice Metallurgy: A Closer Look at Heavy Metal Influence
by: Mukhi Senna, et al.
Published: (2024) -
Role of dendritic cells in MYD88-mediated immune recognition and osteoinduction initiated by the implantation of biomaterials
by: Zifan Zhao, et al.
Published: (2023)